Stockreport

Lexaria's DehydraTECH Significantly Enhances Delivery of Colchicine in Study VIRAL-A20-3

Lexaria Bioscience Corp.  (LEXX) 
PDF Possible Benefits for Treating SARS-CoV-2/COVID-19 and mRNA Vaccine Side EffectsKELOWNA, BC / ACCESSWIRE / July 21, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ: [Read more]